MORF Insider Buying
The table below summarizes the most recent MORF insider buying information — the latest buy being $48,803.04 by Martin Edwards on 11/13/2023, with links to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall Street, there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why MORF insider buys like these are important for investors to follow.
| Date | Insider | Price | Amount |
|---|---|---|---|
| 11-13-2023 Insider Buy |
Martin Edwards Director |
$20.54 CAGR » |
$48,803.04 2,376 shares |
| 11-13-2023 Insider Buy |
Joseph P. Slattery Director |
$20.60 CAGR » |
$49,435.68 2,400 shares |
| 5-3-2023 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$45.00 CAGR » |
$47,250,000.00 1,050,000 shares |
| 5-21-2021 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$45.50 CAGR » |
$10,569,422.50 232,295 shares |
| 5-26-2021 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$46.28 CAGR » |
$6,015,992.41 130,000 shares |
| 5-21-2021 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$45.50 CAGR » |
$10,569,422.50 232,295 shares |
| 3-5-2021 Insider Buy |
Vikas Goyal Director |
$70.00 CAGR » |
$70,000.00 1,000 shares |
| 3-5-2021 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$70.00 CAGR » |
$7,000,000.00 100,000 shares |
| 6-28-2019 Insider Buy |
Holdings A/S Novo >10% Owner |
$15.00 CAGR » |
$10,000,005.00 666,667 shares |
| 7-1-2019 Insider Buy |
Plc Glaxosmithkline Director |
$15.00 CAGR » |
$4,999,995.00 333,333 shares |
| 7-1-2019 Insider Buy |
Omega Fund V, L.P. >10% Owner |
$15.00 CAGR » |
$1,999,995.00 133,333 shares |
| 7-1-2019 Insider Buy |
Otello Stampacchia Director and >10% Owner |
$15.00 CAGR » |
$1,999,995.00 133,333 shares |
| 7-1-2019 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$15.00 CAGR » |
$499,995.00 33,333 shares |
| 7-1-2019 Insider Buy |
Vikas Goyal Director |
$15.00 CAGR » |
$4,999,995.00 333,333 shares |
Also See: SEC filings
MORF Insider Purchase CAGR Analysis
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 11/14/2023 | |
| End date: | 08/16/2024 | |
| Start price/share: | $22.73 | |
| End price/share: | $56.99 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 150.73% | |
| Annualized Gain: | 200.05% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $25,073.00 | |
| Years: | 0.75 | |
